Showing results (1391-1400 of 1,406) with videos related to
Sort By:
Pageof 141
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 8, 2006
The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's diseaseShigeki Arawaka, Manabu Wada, Saori Goto, et al.Lancet (London, England)|July 27, 2023
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 studyShukui Qin, Stephen L Chan, Shanzhi Gu, et al.Journal of Hepatology|May 15, 2013
Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findingsDao-Zhen Xu, Xuan-Yi Wang, Xin-Liang Shen, et al.Journal of Gastroenterology and Hepatology|August 26, 2020
High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3bFanpu Ji, Jie Li, Li Liu, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2019
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 CountriesJin-Lin Hou, Wei Zhao, Changhyeong Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2022
Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II TrialTianyi Wang, Yanjing Tang, Jiaoyang Cai, et al.Plos One|December 17, 2013
AMPK activation through mitochondrial regulation results in increased substrate oxidation and improved metabolic parameters in models of diabetesYonchu Jenkins, Tian-Qiang Sun, Vadim Markovtsov, et al.Plos One|June 9, 2016
Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World DataGuo-Feng Chen, Lai Wei, Jing Chen, et al.Immunobiology|July 26, 2011
Distribution, clinical features and treatment in Taiwanese patients with symptomatic primary immunodeficiency diseases (PIDs) in a nationwide population-based study during 1985-2010Wen-I Lee, Jing-Long Huang, Tang-Her Jaing, et al.Hepatology International|April 14, 2017
CSH guidelines for the diagnosis and treatment of drug-induced liver injuryYue-Cheng Yu, Yi-Min Mao, Cheng-Wei Chen, et al.Pageof 141